Search Results - "Augusto, D"

Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients by Leon, Martin B, Smith, Craig R, Mack, Michael J, Makkar, Raj R, Svensson, Lars G, Kodali, Susheel K, Thourani, Vinod H, Tuzcu, E. Murat, Miller, D. Craig, Herrmann, Howard C, Doshi, Darshan, Cohen, David J, Pichard, Augusto D, Kapadia, Samir, Dewey, Todd, Babaliaros, Vasilis, Szeto, Wilson Y, Williams, Mathew R, Kereiakes, Dean, Zajarias, Alan, Greason, Kevin L, Whisenant, Brian K, Hodson, Robert W, Moses, Jeffrey W, Trento, Alfredo, Brown, David L, Fearon, William F, Pibarot, Philippe, Hahn, Rebecca T, Jaber, Wael A, Anderson, William N, Alu, Maria C, Webb, John G

“…In a randomized trial involving more than 2000 patients, transcatheter aortic-valve replacement was noninferior to surgical replacement in the primary end…”
Get full text

5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial by Kapadia, Samir R, Prof, Leon, Martin B, Prof, Makkar, Raj R, MD, Tuzcu, E Murat, Prof, Svensson, Lars G, Prof, Kodali, Susheel, MD, Webb, John G, Prof, Mack, Michael J, Prof, Douglas, Pamela S, Prof, Thourani, Vinod H, Prof, Babaliaros, Vasilis C, MD, Herrmann, Howard C, Prof, Szeto, Wilson Y, MD, Pichard, Augusto D, MD, Williams, Mathew R, MD, Fontana, Gregory P, MD, Miller, D Craig, Prof, Anderson, William N, PhD, Smith, Craig R, Prof, Akin, Jodi J, Davidson, Michael J

“…Summary Background Based on the early results of the Placement of Aortic Transcatheter Valves (PARTNER) trial, transcatheter aortic valve replacement (TAVR) is…”
Get full text

The S6K protein family in health and disease by Tavares, Mariana R., Pavan, Isadora C.B., Amaral, Camila L., Meneguello, Letícia, Luchessi, Augusto D., Simabuco, Fernando M.

“…The S6K proteins are mTOR pathway effectors and accumulative evidence suggest that mTOR/S6K signaling contributes to several pathological conditions, such as…”
Get full text

Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement by Kodali, Susheel K, Williams, Mathew R, Smith, Craig R, Svensson, Lars G, Webb, John G, Makkar, Raj R, Fontana, Gregory P, Dewey, Todd M, Thourani, Vinod H, Pichard, Augusto D, Fischbein, Michael, Szeto, Wilson Y, Lim, Scott, Greason, Kevin L, Teirstein, Paul S, Malaisrie, S. Chris, Douglas, Pamela S, Hahn, Rebecca T, Whisenant, Brian, Zajarias, Alan, Wang, Duolao, Akin, Jodi J, Anderson, William N, Leon, Martin B

“…This study provides 2-year data from the PARTNER trial, in which patients with aortic stenosis received transcatheter aortic-valve replacement (TAVR) or…”
Get full text

Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients by Smith, Craig R, Leon, Martin B, Mack, Michael J, Miller, D. Craig, Moses, Jeffrey W, Svensson, Lars G, Tuzcu, E. Murat, Webb, John G, Fontana, Gregory P, Makkar, Raj R, Williams, Mathew, Dewey, Todd, Kapadia, Samir, Babaliaros, Vasilis, Thourani, Vinod H, Corso, Paul, Pichard, Augusto D, Bavaria, Joseph E, Herrmann, Howard C, Akin, Jodi J, Anderson, William N, Wang, Duolao, Pocock, Stuart J

“…This study examines use of an expandable bovine pericardial prosthetic valve inserted with a catheter system for valvular aortic stenosis. Outcomes were…”
Get full text

Incidence and predictors of acute kidney injury after transcatheter aortic valve replacement by Barbash, Israel M., MD, Ben-Dor, Itsik, MD, Dvir, Danny, MD, Maluenda, Gabriel, MD, Xue, Zhenyi, MS, Torguson, Rebecca, MPH, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Background Patients undergoing transcatheter aortic valve replacement (TAVR) are at increased risk for acute kidney injury (AKI). The Valve Academic Research…”
Get full text

Terlipressin versus norepinephrine in the treatment of hepatorenal syndrome: a systematic review and meta-analysis by Nassar Junior, Antonio Paulo, Farias, Alberto Queiroz, D' Albuquerque, Luiz Augusto Carneiro, Carrilho, Flair José, Malbouisson, Luiz Marcelo Sá

“…Hepatorenal syndrome (HRS) is a severe and progressive functional renal failure occurring in patients with cirrhosis and ascites. Terlipressin is recognized as…”
Get full text

Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial by Makkar, Raj R, Cheng, Wen, Waksman, Ron, Satler, Lowell F, Chakravarty, Tarun, Groh, Mark, Abernethy, William, Russo, Mark J, Heimansohn, David, Hermiller, James, Worthley, Stephen, Chehab, Bassem, Cunningham, Mark, Matthews, Ray, Ramana, Ravi K, Yong, Gerald, Ruiz, Carlos E, Chen, Chunguang, Asch, Federico M, Nakamura, Mamoo, Jilaihawi, Hasan, Sharma, Rahul, Yoon, Sung-Han, Pichard, Augusto D, Kapadia, Samir, Reardon, Michael J, Bhatt, Deepak L, Fontana, Gregory P

“…Randomised trial data assessing the safety and efficacy of the self-expanding intra-annular Portico transcatheter aortic valve system (Abbott Structural Heart,…”
Get full text

Complications and Outcome of Balloon Aortic Valvuloplasty in High-Risk or Inoperable Patients by Ben-Dor, Itsik, MD, Pichard, Augusto D., MD, Satler, Lowell F., MD, Goldstein, Steven A., MD, Syed, Asmir I., MD, Gaglia, Michael A., MD, MSc, Weissman, Gaby, MD, Maluenda, Gabriel, MD, Gonzalez, Manuel A., MD, MPH, Wakabayashi, Kohei, MD, Collins, Sara D., MD, Torguson, Rebecca, MPH, Okubagzi, Petros, MD, Xue, Zhenyi, MS, Kent, Kenneth M., MD, PhD, Lindsay, Joseph, MD, Waksman, Ron, MD

“…Objectives This study aimed to determine the success, complications, and survival of patients after balloon aortic valvuloplasty (BAV). Background The…”
Get full text

Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery by Leon, Martin B, Smith, Craig R, Mack, Michael, Miller, D. Craig, Moses, Jeffrey W, Svensson, Lars G, Tuzcu, E. Murat, Webb, John G, Fontana, Gregory P, Makkar, Raj R, Brown, David L, Block, Peter C, Guyton, Robert A, Pichard, Augusto D, Bavaria, Joseph E, Herrmann, Howard C, Douglas, Pamela S, Petersen, John L, Akin, Jodi J, Anderson, William N, Wang, Duolao, Pocock, Stuart

“…Patients with aortic stenosis underwent transfemoral transcatheter implantation of a balloon-expandable bovine pericardial aortic valve. One-year mortality was…”
Get full text

Choice of Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valve Impacts Hemodynamics Differently According to Aortic Annular Size by Rogers, Toby, BM, BCh, PhD, Steinvil, Arie, MD, Gai, Jiaxiang, MSPH, Torguson, Rebecca, MPH, Koifman, Edward, MD, Kiramijyan, Sarkis, MD, Negi, Smita, MD, Lee, Sang Yeub, MD, Okubagzi, Petros, MD, Satler, Lowell F., MD, Ben-Dor, Itsik, MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Abstract We sought to determine whether balloon-expandable (BEV) and self-expanding (SEV) valves affect valve hemodynamics differently according to native…”
Get full text

Blown spun fibers-based colorimetric sensor for detecting trace zinc in seminal fluid by de Oliveira S. Silva, Jonatas, Alvarenga, Augusto D., Correa, Daniel S., Mercante, Luiza A., Santana, Rodolfo M.M.

“…Rapid and accurate analysis of zinc in seminal fluid is an important tool for male infertility diagnosis and forensic investigation of sexual assault. Among…”
Get full text

Insights Into Timing, Risk Factors, and Outcomes of Stroke and Transient Ischemic Attack After Transcatheter Aortic Valve Replacement in the PARTNER Trial (Placement of Aortic Transcatheter Valves) by Kapadia, Samir, Agarwal, Shikhar, Miller, D Craig, Webb, John G, Mack, Michael, Ellis, Stephen, Herrmann, Howard C, Pichard, Augusto D, Tuzcu, E Murat, Svensson, Lars G, Smith, Craig R, Rajeswaran, Jeevanantham, Ehrlinger, John, Kodali, Susheel, Makkar, Raj, Thourani, Vinod H, Blackstone, Eugene H, Leon, Martin B

“…BACKGROUND—Prior studies of stroke and transient ischemic attack (TIA) after transcatheter aortic valve replacement (TAVR) are limited by reporting and…”
Get full text

The relative performance characteristics of the logistic European System for Cardiac Operative Risk Evaluation score and the Society of Thoracic Surgeons score in the Placement of Aortic Transcatheter Valves trial by Beohar, Nirat, MD, FACC, FSCAI, Whisenant, Brian, MD, Kirtane, Ajay J., MD, SM, Leon, Martin B., MD, Tuzcu, E. Murat, MD, Makkar, Raj, MD, Svensson, Lars G., MD, PhD, Miller, D. Craig, MD, Smith, Craig R., MD, Pichard, Augusto D., MD, Herrmann, Howard C., MD, Thourani, Vinod H., MD, Szeto, Wilson Y., MD, Lim, Scott, MD, Fischbein, Michael, MD, Fearon, William F., MD, O'Neill, William, MD, Xu, Ke, PhD, Dewey, Todd, MD, Mack, Michael, MD

“…Objectives The logistic European System for Cardiac Operative Risk Evaluation (LES) score and the Society of Thoracic Surgeons (STS) score are validated to…”
Get full text

3D Bioprinting Technology and Hydrogels Used in the Process by Lima, Tainara de P L, Canelas, Caio Augusto D A, Concha, Viktor O C, Costa, Fernando A M da, Passos, Marcele F

“…3D bioprinting has gained visibility in regenerative medicine and tissue engineering due to its applicability. Over time, this technology has been optimized…”
Get full text

A First-in-Man, Randomized, Placebo-Controlled Study to Evaluate the Safety and Feasibility of Autologous Delipidated High-Density Lipoprotein Plasma Infusions in Patients With Acute Coronary Syndrome by Waksman, Ron, MD, Torguson, Rebecca, MPH, Kent, Kenneth M., MD, PhD, Pichard, Augusto D., MD, Suddath, William O., MD, Satler, Lowell F., MD, Martin, Brenda D., RN, Perlman, Timothy J., BSME, Maltais, Jo-Ann B., PhD, Weissman, Neil J., MD, Fitzgerald, Peter J., MD, Brewer, H. Bryan, MD

“…Objectives This study aimed to determine whether serial autologous infusions of selective high-density lipoprotein (HDL) delipidated plasma are feasible and…”
Get full text

Long-Term Outcomes of Inoperable Patients With Aortic Stenosis Randomly Assigned to Transcatheter Aortic Valve Replacement or Standard Therapy by Kapadia, Samir R, Tuzcu, E Murat, Makkar, Raj R, Svensson, Lars G, Agarwal, Shikhar, Kodali, Susheel, Fontana, Gregory P, Webb, John G, Mack, Michael, Thourani, Vinod H, Babaliaros, Vasilis C, Herrmann, Howard C, Szeto, Wilson, Pichard, Augusto D, Williams, Mathew R, Anderson, William N, Akin, Jodi J, Miller, D Craig, Smith, Craig R, Leon, Martin B

“…BACKGROUND—The long-term outcomes of transcatheter aortic valve replacement (TAVR) in inoperable patients with severe aortic stenosis remain unknown. METHODS…”
Get full text

Impact of Pre-Procedural Serum Albumin Levels on Outcome of Patients Undergoing Transcatheter Aortic Valve Replacement by Koifman, Edward, MD, Magalhaes, Marco A., MD, Ben-Dor, Itsik, MD, Kiramijyan, Sarkis, MD, Escarcega, Ricardo O., MD, Fang, Chen, PhD, Torguson, Rebecca, MPH, Okubagzi, Petros, MD, Negi, Smita I., MD, Baker, Nevin C., DO, Minha, Sa'ar, MD, Corso, Paul J., MD, Shults, Christian, MD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Risk assessment for transcatheter aortic valve replacement (TAVR) patients is challenging, and surgical scores do not optimally correlate with outcome. The aim…”
Get full text

Behçet disease, new insights in disease associations and manifestations: a next‐generation sequencing study by Elfishawi, M., Mossallam, G., Augusto, D. G., Montero‐Martin, G., Bruin, H., Van de Pasch, L., Norman, P. J., Rozemuller, E., Fernandez‐Vina, M., Abrudescu, A., Hollenbach, J. A., Zaky, K., Elfishawi, S.

“…Summary Behçet disease is a multi‐system disease associated with human leukocyte antigen (HLA) class I polymorphism. High‐resolution next‐generation sequencing…”
Get full text

Health-Related Quality of Life After Transcatheter Aortic Valve Replacement in Inoperable Patients With Severe Aortic Stenosis by REYNOLDS, Matthew R, MAGNUSON, Elizabeth A, HERRMANN, Howard C, KAPADIA, Samir, KODALI, Susheel K, MAKKAR, Raj R, PICHARD, Augusto D, COHEN, David J, YANG LEI, LEON, Martin B, SMITH, Craig R, SVENSSON, Lars G, WEBB, John G, BABALIAROS, Vasilis C, BOWERS, Bruce S, FEARON, William F

“…Background- Transcatheter aortic valve replacement (TAVR) has been shown to improve survival compared with standard therapy in patients with severe aortic…”
Get full text